Description of multiple myeloma cases and assessment of survival and mortality factors in Madagascar
CONCLUSION: Patient survival is shorter than reported in the literature. The high mortality rate is due to comorbidities and limited access to recommended therapies.PMID:37746751 | DOI:10.1080/16078454.2023.2261803
Source: Hematology - Category: Hematology Authors: Rova Malala Fandresena Randrianarisoa Val éry Refeno Ny Ony Tiana Florence Andrianandrasana Fidiarivony Ralison Hanta Marie Danielle Vololontiana Florine Rafaramino Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chronic Kidney Disease | Chronic Pain | Epidemiology | Hematology | Hypertension | Kidney Transplant | Kidney Transplantation | Madagascar Health | Myeloma | Orthopaedics | Pain | Prednisone | Renal Failure | Smokers | Stem Cell Therapy | Stem Cells | Study | Teaching | Teaching Hospitals | Transplants | Universities & Medical Training | Urology & Nephrology